Literature DB >> 20691668

Irreversible inhibition of RANK expression as a possible mechanism for IL-3 inhibition of RANKL-induced osteoclastogenesis.

Shruti M Khapli1, Geetanjali B Tomar, Amruta P Barhanpurkar, Navita Gupta, S D Yogesha, Satish T Pote, Mohan R Wani.   

Abstract

IL-3, a cytokine secreted by activated T lymphocytes, stimulates the proliferation, differentiation and survival of pluripotent hematopoietic stem cells. In this study, we investigated the mechanism of inhibitory action of IL-3 on osteoclast differentiation. We show here that IL-3 significantly inhibits receptor activator of NF-kappaB (RANK) ligand (RANKL)-induced activation of c-Jun N-terminal kinase (JNK). IL-3 down-regulates expression of c-Fos and nuclear factor of activated T cells (NFATc1) transcription factors. In addition, IL-3 down-regulates RANK expression posttranscriptionally in both purified osteoclast precursors and whole bone marrow cells. Furthermore, the inhibitory effect of IL-3 on RANK expression was irreversible. Interestingly, IL-3 inhibits in vivo RANK expression in mice. Thus, we provide the first evidence that IL-3 irreversibly inhibits RANK expression that results in inhibition of important signaling molecules induced by RANKL. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691668     DOI: 10.1016/j.bbrc.2010.07.143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.

Authors:  Huixian Hong; Zhenqi Shi; Ping Qiao; Hui Li; Erin M McCoy; Ping Mao; Hui Xu; Xu Feng; Shunqing Wang
Journal:  Biochem Biophys Res Commun       Date:  2013-10-05       Impact factor: 3.575

2.  Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration.

Authors:  Anastasios D Papanastasiou; Chaido Sirinian; Haralabos P Kalofonos
Journal:  Breast Cancer Res       Date:  2012-07-23       Impact factor: 6.466

3.  STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis.

Authors:  Jongwon Lee; Semun Seong; Jung Ha Kim; Kabsun Kim; Inyoung Kim; Byung-Chul Jeong; Kwang-Il Nam; Kyung Keun Kim; Lothar Hennighausen; Nacksung Kim
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

4.  Potential mechanisms of osteoprotegerin-induced damage to osteoclast adhesion structures via P2X7R-mediated MAPK signaling.

Authors:  Yonggang Ma; Xueni Shi; Hongyan Zhao; Ruilong Song; Hui Zou; Jiaqiao Zhu; Zongping Liu
Journal:  Int J Mol Med       Date:  2022-03-10       Impact factor: 4.101

Review 5.  Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology.

Authors:  Kyunghee Lee; Incheol Seo; Mun Hwan Choi; Daewon Jeong
Journal:  Int J Mol Sci       Date:  2018-10-01       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.